North America Botulinum Toxin Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)

No. of Pages: 77    |    Report Code: TIPRE00028644    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Botulinum Toxin Market

1.        Introduction

1.1      The Insight Partners Research Report Guidance

1.2      Market Segmentation

2.        Executive Summary

2.1      Key Insights

3.        Research Methodology

3.1      Coverage

3.2      Secondary Research

3.3      Primary Research

4.        North America Botulinum Toxin Market – Key Market Dynamics

4.1      Market Drivers

4.1.1       Rising Popularity of Noninvasive Aesthetics Procedures

4.1.2       Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics

4.2      Market Restraints

4.2.1       Side Effects of Botulinum Toxin

4.3      Market Opportunities

4.3.1       Rising Adoption of Aesthetic Procedure in Emerging Economies

4.4      Future Trends

4.4.1       Expanding Therapeutic Applications

4.5      Impact of Drivers and Restraints:

5.        Botulinum Toxin Market – North America Analysis

5.1      Overview

5.2      Botulinum Toxin Market Revenue (US$ Million), 2021–2031

6.        North America Botulinum Toxin Market Analysis – by Product

6.1      Overview

6.2      Botulinum Toxin A

6.2.1       Overview

6.2.2       Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

6.3      Botulinum Toxin B

6.3.1       Overview

6.3.2       Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

7.        North America Botulinum Toxin Market Analysis – by Application

7.1      Overview

7.2      Medical

7.2.1       Overview

7.2.2       Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

7.2.2.1         North America Botulinum Toxin Market Breakdown, by Medical

7.3      Aesthetic

7.3.1       Overview

7.3.2       Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

7.3.2.1         North America Botulinum Toxin Market Breakdown, by Aesthetic

8.        North America Botulinum Toxin Market Analysis – by End User

8.1      Overview

8.2      Specialty and Dermatology Clinics

8.2.1       Overview

8.2.2       Specialty and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

8.3      Hospitals and Clinics

8.3.1       Overview

8.3.2       Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

8.4      Others

8.4.1       Overview

8.4.2       Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.        North America Botulinum Toxin Market – Country Analysis

9.1      North America: Botulinum Toxin Market

9.1.1       North America: Botulinum Toxin Market – Revenue and Forecast Analysis – by Country

9.1.1.1         United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.1.1        Overview

9.1.1.1.2        United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.1.3        United States: Botulinum Toxin Market Breakdown, by Product

9.1.1.1.4        United States: Botulinum Toxin Market Breakdown, by Application

9.1.1.1.4.1       United States: Botulinum Toxin Market Breakdown, by Medical

9.1.1.1.4.2       United States: Botulinum Toxin Market Breakdown, by Aesthetic

9.1.1.1.5        United States: Botulinum Toxin Market Breakdown, by End User

9.1.1.2         Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.2.1        Overview

9.1.1.2.2        Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.2.3        Canada: Botulinum Toxin Market Breakdown, by Product

9.1.1.2.4        Canada: Botulinum Toxin Market Breakdown, by Application

9.1.1.2.4.1       Canada: Botulinum Toxin Market Breakdown, by Medical

9.1.1.2.4.2       Canada: Botulinum Toxin Market Breakdown, by Aesthetic

9.1.1.2.5        Canada: Botulinum Toxin Market Breakdown, by End User

9.1.1.3         Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.3.1        Overview

9.1.1.3.2        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

9.1.1.3.3        Mexico: Botulinum Toxin Market Breakdown, by Product

9.1.1.3.4        Mexico: Botulinum Toxin Market Breakdown, by Application

9.1.1.3.4.1       Mexico: Botulinum Toxin Market Breakdown, by Medical

9.1.1.3.4.2       Mexico: Botulinum Toxin Market Breakdown, by Aesthetic

9.1.1.3.5        Mexico: Botulinum Toxin Market Breakdown, by End User

10.      Company Profiles

10.1    Merz Pharma GmbH & Co KGaA

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2    AbbVie Inc

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3    Ipsen SA

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4    Evolus Inc

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5    Aquavit

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6    Revance Therapeutics Inc

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7    Medytox Inc

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8    Galderma SA

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9    Hugel Inc

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     SWOT Analysis

10.9.6     Key Developments

10.10  Lanzhou Institute of Biological Products Co Ltd

10.10.1   Key Facts

10.10.2   Business Description

10.10.3   Products and Services

10.10.4   Financial Overview

10.10.5   SWOT Analysis

10.10.6   Key Developments

11.      Appendix

11.1    About The Insight Partners

List of Tables

Table 1.          Botulinum Toxin Market Segmentation

Table 2.          North America Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical

Table 3.          North America Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic

Table 4.          United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 5.          United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 6.          United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical

Table 7.          United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic

Table 8.          United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 9.          Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 10.        Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 11.        Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical

Table 12.        Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic

Table 13.        Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 14.        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 15.        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 16.        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Medical

Table 17.        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by Aesthetic

Table 18.        Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 19.        Glossary of Terms

List of Figures

Figure 1.         Botulinum Toxin Market Segmentation, by Country

Figure 2.         Botulinum Toxin Market – Key Market Dynamics

Figure 3.         Impact Analysis of Drivers and Restraints

Figure 4.         Botulinum Toxin Market Revenue (US$ Million), 2021–2031

Figure 5.         Botulinum Toxin Market Share (%) – by Product (2023 and 2031)

Figure 6.         Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.         Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.         Botulinum Toxin Market Share (%) – by Application (2023 and 2031)

Figure 9.         Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.      Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.      Botulinum Toxin Market Share (%) – by End User (2023 and 2031)

Figure 12.      Specialty and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.      Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.      Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.      North America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million)

Figure 16.      North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 17.      United States: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.      Canada: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.      Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million)

The List of Companies - North America Botulinum Toxin Market

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Ipsen SA
  • Evolus Inc
  • Aquavit
  • Revance Therapeutics Inc            
  • Medytox Inc
  • Galderma SA
  • Hugel Inc
  • Lanzhou Institute of Biological Products Co Ltd